Deakin University
Browse

Evaluation of silibinin effects on the viability of HepG2 (Human hepatocellular liver carcinoma) and HUVEC (human umbilical vein endothelial) cell lines

Download (515.91 kB)
Version 3 2024-06-19, 06:44
Version 2 2024-06-13, 14:55
Version 1 2021-11-22, 10:33
journal contribution
posted on 2024-06-19, 06:44 authored by N Vakili Zahir, M Nakhjavani, P Hajian, FH Shirazi, H Mirzaei
Evaluation of silibinin effects on the viability of HepG2 (Human hepatocellular liver carcinoma) and HUVEC (human umbilical vein endothelial) cell lines

History

Journal

Iranian Journal of Pharmaceutical Research

Volume

17

Season

Winter

Pagination

261-267

Location

Netherlands

Publisher DOI

Open access

  • Yes

Link to full text

ISSN

1735-0328

eISSN

1726-6890

Language

English

Author URL

Publication classification

C1 Refereed article in a scholarly journal

Issue

1

Publisher

SHAHEED BEHESHTI UNIV, SCH PHARMACY

Usage metrics

    Research Publications

    Categories

    Keywords

    Science & TechnologyLife Sciences & BiomedicinePharmacology & PharmacySilibininHuman hepatocellular carcinomaHUVECHepG2ACTIVATED PROTEIN-KINASESMILK THISTLEPROSTATE-CANCERCYCLE ARRESTINHIBITS GROWTHKAPPA-BSILYMARINAPOPTOSISCHEMOPREVENTIONPROLIFERATION3214 Pharmacology and pharmaceutical sciences

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC